Related Experiment Video
Updated: Sep 10, 2025

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
Coevolutionary phage training expands phage host range: Driven by tail fiber mutations in Pseudomonas aeruginosa
Zixun Lin1, Xiangke Duan2, Xiaofu Wan2
1National Clinical Research Center for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China; School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Abstract:
The rise of antibiotic-resistant bacteria, particularly multidrug-resistant Pseudomonas aeruginosa (P. aeruginosa), represents a critical challenge to global health security. Bacteriophages, with their ability to target and lyse specific bacterial pathogens, present a promising alternative through phage therapy. However, their narrow host range limits therapeutic applications. In this study, we developed an evolutionary system to expand the host range of P. aeruginosa phage pap17. Through one-host and dual-host experimental evolution, pap17 was co-cultured with permissive and non-permissive bacterial hosts. Post-evolution, pap17 gained the ability to infect previously non-permissive strains while retaining infectivity against original hosts. Genomic analysis identified key mutations in the tail fiber protein, critical for host range expansion. Evolved phages exhibited enhanced stability and lytic activity under varying environmental conditions. These findings demonstrate that evolved phages can be trained to combat a broader range of antibiotic-resistant strains, offering a potential solution to multidrug-resistant P. aeruginosa infections.
Insights
Bacteriophages (viruses that infect bacteria) were evolved to broaden their attack range against multidrug-resistant Pseudomonas aeruginosa. This enhanced phage therapy offers a new strategy to combat dangerous bacterial infections.
Area of Science:
- Microbiology
- Genetics
- Biotechnology
Background:
- Antibiotic-resistant bacteria, like Pseudomonas aeruginosa, pose a significant global health threat.
- Bacteriophage therapy is a promising alternative to antibiotics but is limited by narrow host specificity.
Purpose of the Study:
- To engineer the host range of Pseudomonas aeruginosa phage pap17.
- To develop an evolutionary strategy for enhancing phage efficacy against resistant bacterial strains.
Main Methods:
- Experimental evolution involving co-culturing phage pap17 with permissive and non-permissive Pseudomonas aeruginosa strains.
- Genomic analysis to identify mutations responsible for host range expansion.
- Assessment of evolved phages' stability and lytic activity.
Main Results:
- Evolved pap17 phages acquired the ability to infect previously non-permissive strains.
- Infectivity against original hosts was maintained.
- Key mutations were identified in the phage's tail fiber protein.
- Evolved phages showed improved stability and lytic activity.
Conclusions:
- Experimental evolution can successfully broaden bacteriophage host range.
- Engineered phages demonstrate potential for combating multidrug-resistant Pseudomonas aeruginosa.
- This approach offers a viable strategy to enhance phage therapy effectiveness.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
DNA Bacteriophages
Transduction

